Manel Alcalà, appointed member of the European Pharmacopoeia

28/11/2022

The European Pharmacopoeia provides common quality standards for the entire pharmaceutical industry in Europe so as to control the quality of drugs and substances used to manufacture them. It forms part of the European Directorate for the Quality of Medicines and Healthcare (EDQM), an organisation created by the Council of Europe whose mission is to contribute to improving the access to drugs and quality healthcare, and to promote and protect human and animal health. In the 174th session fo the EDQM Commission in Strasbourg, held on 22 November 2022, Manel Alcalà was appointed member of the organisation's group of experts.

Manel Alcalà was appointed based on his experience as a member of several different working groups: Spectroscopy and Data Analysis (SDA), Process Analytical Technology (PAT) and Analytical Quality by Design (AQbD). These groups were in charge of drafting and updating pharmacopoeia monographs which make up the scientific basis for quality control for pharmaceutical laboratories operating in the EU member states.

Members are appointed to the European Directorate for the Quality of Medicines and Healthcare for a total of three years. Manel Alcalà was elected in representation of the Spanish Agency of Medicines and Medical Devices (AEMPS) of the Spanish Ministry for Health.